XPO6_HUMAN - dbPTM
XPO6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID XPO6_HUMAN
UniProt AC Q96QU8
Protein Name Exportin-6
Gene Name XPO6
Organism Homo sapiens (Human).
Sequence Length 1125
Subcellular Localization Nucleus. Cytoplasm. Shuttles between the nucleus and the cytoplasm.
Protein Description Mediates the nuclear export of actin and profilin-actin complexes in somatic cells..
Protein Sequence MASEEASLRALESLMTEFFHDCTTNERKREIEELLNNFAQQIGAWRFCLYFLSSTRNDYVMMYSLTVFENLINKMWLGVPSQDKMEIRSCLPKLLLAHHKTLPYFIRNKLCKVIVDIGRQDWPMFYHDFFTNILQLIQSPVTTPLGLIMLKTTSEELACPREDLSVARKEELRKLLLDQVQTVLGLLTGILETVWDKHSVTAATPPPSPTSGESGDLLSNLLQSPSSAKLLNQPIPILDVESEYICSLALECLAHLFSWIPLSASITPSLLTTIFHFARFGCDIRARKMASVNGSSQNCVSGQERGRLGVLAMSCINELMSKNCVPMEFEEYLLRMFQQTFYLLQKITKDNNAHTVKSRLEELDESYIEKFTDFLRLFVSVHLRRIESYSQFPVVEFLTLLFKYTFHQPTHEGYFSCLDIWTLFLDYLTSKIKSRLGDKEAVLNRYEDALVLLLTEVLNRIQFRYNQAQLEELDDETLDDDQQTEWQRYLRQSLEVVAKVMELLPTHAFSTLFPVLQDNLEVYLGLQQFIVTSGSGHRLNITAENDCRRLHCSLRDLSSLLQAVGRLAEYFIGDVFAARFNDALTVVERLVKVTLYGSQIKLYNIETAVPSVLKPDLIDVHAQSLAALQAYSHWLAQYCSEVHRQNTQQFVTLISTTMDAITPLISTKVQDKLLLSACHLLVSLATTVRPVFLISIPAVQKVFNRITDASALRLVDKAQVLVCRALSNILLLPWPNLPENEQQWPVRSINHASLISALSRDYRNLKPSAVAPQRKMPLDDTKLIIHQTLSVLEDIVENISGESTKSRQICYQSLQESVQVSLALFPAFIHQSDVTDEMLSFFLTLFRGLRVQMGVPFTEQIIQTFLNMFTREQLAESILHEGSTGCRVVEKFLKILQVVVQEPGQVFKPFLPSIIALCMEQVYPIIAERPSPDVKAELFELLFRTLHHNWRYFFKSTVLASVQRGIAEEQMENEPQFSAIMQAFGQSFLQPDIHLFKQNLFYLETLNTKQKLYHKKIFRTAMLFQFVNVLLQVLVHKSHDLLQEEIGIAIYNMASVDFDGFFAAFLPEFLTSCDGVDANQKSVLGRNFKMDRDLPSFTQNVHRLVNDLRYYRLCNDSLPPGTVKL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASEEASLR
------CCCHHHHHH
36.6322223895
79UbiquitinationINKMWLGVPSQDKME
HHHHCCCCCCCCHHH
3.7429967540
93AcetylationEIRSCLPKLLLAHHK
HHHHHHHHHHHHHHC
38.5325953088
93UbiquitinationEIRSCLPKLLLAHHK
HHHHHHHHHHHHHHC
38.5329967540
152PhosphorylationLGLIMLKTTSEELAC
CCEEEEECCCHHHCC
31.43-
153PhosphorylationGLIMLKTTSEELACP
CEEEEECCCHHHCCC
32.33-
154PhosphorylationLIMLKTTSEELACPR
EEEEECCCHHHCCCH
34.01-
175UbiquitinationRKEELRKLLLDQVQT
CHHHHHHHHHHHHHH
4.6727667366
183UbiquitinationLLDQVQTVLGLLTGI
HHHHHHHHHHHHHHH
1.9222817900
190PhosphorylationVLGLLTGILETVWDK
HHHHHHHHHHHHHHH
2.3732142685
194PhosphorylationLTGILETVWDKHSVT
HHHHHHHHHHHCCCC
4.5532142685
199PhosphorylationETVWDKHSVTAATPP
HHHHHHCCCCCCCCC
27.2329255136
201PhosphorylationVWDKHSVTAATPPPS
HHHHCCCCCCCCCCC
17.3729255136
204PhosphorylationKHSVTAATPPPSPTS
HCCCCCCCCCCCCCC
33.5929255136
208PhosphorylationTAATPPPSPTSGESG
CCCCCCCCCCCCCCC
46.7329255136
210PhosphorylationATPPPSPTSGESGDL
CCCCCCCCCCCCCCH
54.4229255136
211PhosphorylationTPPPSPTSGESGDLL
CCCCCCCCCCCCCHH
43.9029255136
214PhosphorylationPSPTSGESGDLLSNL
CCCCCCCCCCHHHHH
40.9229255136
219PhosphorylationGESGDLLSNLLQSPS
CCCCCHHHHHHCCCC
32.5029255136
224PhosphorylationLLSNLLQSPSSAKLL
HHHHHHCCCCHHHHH
27.0730278072
226PhosphorylationSNLLQSPSSAKLLNQ
HHHHCCCCHHHHHCC
48.4530278072
227PhosphorylationNLLQSPSSAKLLNQP
HHHCCCCHHHHHCCC
32.5730278072
274UbiquitinationTPSLLTTIFHFARFG
CHHHHHHHHHHHHHC
1.81-
275UbiquitinationPSLLTTIFHFARFGC
HHHHHHHHHHHHHCC
3.4927667366
283UbiquitinationHFARFGCDIRARKMA
HHHHHCCCCCCHHHH
33.5122817900
288UbiquitinationGCDIRARKMASVNGS
CCCCCCHHHHHCCCC
37.52-
296PhosphorylationMASVNGSSQNCVSGQ
HHHCCCCCCCCCCCC
27.15-
305MethylationNCVSGQERGRLGVLA
CCCCCCCCCHHHHHH
27.87-
307MethylationVSGQERGRLGVLAMS
CCCCCCCHHHHHHHH
34.19-
314PhosphorylationRLGVLAMSCINELMS
HHHHHHHHHHHHHHH
13.2625072903
321PhosphorylationSCINELMSKNCVPME
HHHHHHHHCCCCCCC
33.0825072903
332PhosphorylationVPMEFEEYLLRMFQQ
CCCCHHHHHHHHHHH
12.1125332170
335UbiquitinationEFEEYLLRMFQQTFY
CHHHHHHHHHHHHHH
22.6727667366
340PhosphorylationLLRMFQQTFYLLQKI
HHHHHHHHHHHHHHH
11.9425332170
342PhosphorylationRMFQQTFYLLQKITK
HHHHHHHHHHHHHHC
15.1925332170
343UbiquitinationMFQQTFYLLQKITKD
HHHHHHHHHHHHHCC
3.4021906983
343UbiquitinationMFQQTFYLLQKITKD
HHHHHHHHHHHHHCC
3.4022817900
349UbiquitinationYLLQKITKDNNAHTV
HHHHHHHCCCCCHHH
63.0327667366
356UbiquitinationKDNNAHTVKSRLEEL
CCCCCHHHHHHHHHH
3.6829901268
357UbiquitinationDNNAHTVKSRLEELD
CCCCHHHHHHHHHHC
30.8922817900
370UbiquitinationLDESYIEKFTDFLRL
HCHHHHHHHHHHHHH
43.9629901268
421UbiquitinationYFSCLDIWTLFLDYL
CCHHHHHHHHHHHHH
6.1622817900
542PhosphorylationSGHRLNITAENDCRR
CCCCEEEECCCHHHH
27.1825841592
558PhosphorylationHCSLRDLSSLLQAVG
CCCHHHHHHHHHHHH
24.1921712546
585PhosphorylationARFNDALTVVERLVK
HHHHHHHHHHHHHHH
24.99-
592UbiquitinationTVVERLVKVTLYGSQ
HHHHHHHHHEEECCE
33.8122817900
647PhosphorylationSEVHRQNTQQFVTLI
HHHHHHCHHHHHHHH
18.53-
652PhosphorylationQNTQQFVTLISTTMD
HCHHHHHHHHHHHHH
21.4720071362
655PhosphorylationQQFVTLISTTMDAIT
HHHHHHHHHHHHHHH
22.42-
657PhosphorylationFVTLISTTMDAITPL
HHHHHHHHHHHHHHH
13.2820071362
662PhosphorylationSTTMDAITPLISTKV
HHHHHHHHHHHCHHH
17.4820071362
666PhosphorylationDAITPLISTKVQDKL
HHHHHHHCHHHHHHH
29.8324719451
692UbiquitinationATTVRPVFLISIPAV
HHCCCCEEEEHHHHH
5.7822817900
703UbiquitinationIPAVQKVFNRITDAS
HHHHHHHHHHCCCHH
7.01-
717UbiquitinationSALRLVDKAQVLVCR
HHHHHCCHHHHHHHH
32.99-
752UbiquitinationPVRSINHASLISALS
CCCCCCHHHHHHHHH
11.0922817900
752UbiquitinationPVRSINHASLISALS
CCCCCCHHHHHHHHH
11.0921906983
766UbiquitinationSRDYRNLKPSAVAPQ
HCCHHCCCCCCCCCC
40.2421906983
781PhosphorylationRKMPLDDTKLIIHQT
CCCCCCCCHHHHHHH
27.67-
788PhosphorylationTKLIIHQTLSVLEDI
CHHHHHHHHHHHHHH
13.56-
804PhosphorylationENISGESTKSRQICY
HHCCCCCHHHHHHHH
28.83-
891UbiquitinationTGCRVVEKFLKILQV
CHHHHHHHHHHHHHH
44.37-
956PhosphorylationNWRYFFKSTVLASVQ
CHHHHHHHHHHHHHH
20.7020068231
957PhosphorylationWRYFFKSTVLASVQR
HHHHHHHHHHHHHHH
21.8220068231
961PhosphorylationFKSTVLASVQRGIAE
HHHHHHHHHHHCCCH
18.0220068231

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of XPO6_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of XPO6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of XPO6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NUP62_HUMANNUP62physical
16189514
VASP_HUMANVASPphysical
14592989
RAN_HUMANRANphysical
14592989
ACTS_HUMANACTA1physical
14592989
PROF1_HUMANPFN1physical
14592989
DIAP1_HUMANDIAPH1physical
14592989
ENAH_HUMANENAHphysical
14592989
NUP62_HUMANNUP62physical
25416956
NUP62_HUMANNUP62physical
21516116
MTOR_HUMANMTORphysical
27173435
THADA_HUMANTHADAphysical
27173435
LST8_HUMANMLST8physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of XPO6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199; THR-201; THR-204AND SER-224, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-204 AND SER-208, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-204; THR-210 ANDSER-224, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-204; THR-210 ANDSER-224, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-204; THR-204; SER-208AND SER-214, AND MASS SPECTROMETRY.

TOP